Xu, S., Chen, W., & Li, Y. (2024). Daratumumab-based regimen for newly diagnosed multiple myeloma patients with paraskeletal plasmacytomas: A retrospective study in a single center. Hematology (Luxembourg), 29(1), 2431958. https://doi.org/10.1080/16078454.2024.2431958
Citace podle Chicago (17th ed.)Xu, Shuiqing, Wenming Chen, a Yanchen Li. "Daratumumab-based Regimen for Newly Diagnosed Multiple Myeloma Patients with Paraskeletal Plasmacytomas: A Retrospective Study in a Single Center." Hematology (Luxembourg) 29, no. 1 (2024): 2431958. https://doi.org/10.1080/16078454.2024.2431958.
Citace podle MLA (9th ed.)Xu, Shuiqing, et al. "Daratumumab-based Regimen for Newly Diagnosed Multiple Myeloma Patients with Paraskeletal Plasmacytomas: A Retrospective Study in a Single Center." Hematology (Luxembourg), vol. 29, no. 1, 2024, p. 2431958, https://doi.org/10.1080/16078454.2024.2431958.